North America Bioanalytical Testing Services Market Report 2022: Rising Demand for Analytical Testing of Biologics and Biosimilars & Increasing Preference for Outsourcing Driving Growth - ResearchAndMarkets.com
The North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country.
Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Small Molecules
Large Molecules
LC-MS Studies
Immunoassays
Other Large Molecule Tests
Based Application, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
By Test Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Cell-based Assays
Bacterial Cell-based Assays
Viral Cell-based Assays
Virology Testing
In Vitro Virology Testing
In Vivo Virology Testing
Species-Specific Viral PCR Assays
Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
Viral Serology, Immunogenicity, and Neutralizing Antibodies
Method Development Optimization and Validation (MDOV)
Biomarker Testing
Pharmacokinetic Testing
Other Test Types
By Workflow Process, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Sample Preparation
Protein Precipitation
Liquid-liquid Extraction (LLE)
Sample Analysis
Hyphenated Technique
Chromatographic Technique
Electrophoresis
Ligand Binding Assay
Mass Spectrometry
Nuclear Magnetic Resonance
Other Workflow Processes
By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Therapeutic Areas
By End User, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Pharma and Biopharma Companies
Contract Development and Manufacturing Organizations (CDMOs)
Contract Research Organizations (CROs)
Selected Key Players:
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of North America Market by Molecule Type
4 Segmentation of North America Market by Application
5 Segmentation of North America Market by Test Type
6 Segmentation of North America Market by Workflow Process
7 Segmentation of North America Market by Therapeutic Area
8 Segmentation of North America Market by End User
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis.
The company's dividend is...
Adyton Resources Corporation ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...